Back to Search
Start Over
Increased APOE ε4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds
- Source :
- Alzheimers Dement
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- INTRODUCTION Apolipoprotein E (APOE) e4 confers less risk for Alzheimer's disease (AD) in carriers with African local genomic ancestry (ALA) than APOE e4 carriers with European local ancestry (ELA). Cell type specific transcriptional variation between the two local ancestries (LAs) could contribute to this disease risk differences. METHODS Single-nucleus RNA sequencing was performed on frozen frontal cortex of homozygous APOE e4/e4 AD patients: seven with ELA, four with ALA. RESULTS A total of 60,908 nuclei were sequenced. Within the LA region (chr19:44-46Mb), APOE was the gene most differentially expressed, with ELA carriers having significantly more expression (overall P
- Subjects :
- Male
0301 basic medicine
Apolipoprotein E
Heterozygote
medicine.medical_specialty
Epidemiology
Apolipoprotein E4
Cell
Black People
Disease
Biology
White People
Article
Transcriptome
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Developmental Neuroscience
Alzheimer Disease
Internal medicine
medicine
Humans
Gene
Alleles
Aged
Aged, 80 and over
Sequence Analysis, RNA
Health Policy
RNA
Psychiatry and Mental health
030104 developmental biology
medicine.anatomical_structure
Endocrinology
Disease risk
Female
lipids (amino acids, peptides, and proteins)
Neurology (clinical)
Geriatrics and Gerontology
030217 neurology & neurosurgery
Astrocyte
Subjects
Details
- ISSN :
- 15525279 and 15525260
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Alzheimer's & Dementia
- Accession number :
- edsair.doi.dedup.....457fa5889bc7cbf1fc5eb794d2c6901f